Centers for Disease Control and Prevention staffers are voicing frustration over Health Secretary Robert F. Kennedy Jr.’s ...

Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

W hen BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...

Kennedy, who has long expressed skepticism about the safety and efficacy of certain vaccines, said the move signals a broader ...

Note that some links may require registration or subscription. DermaRite Industries is recalling certain lots of its over-the ...

Robert F. Kennedy Jr. has announced that his department will end funding for a series of mRNA-based vaccines aimed at ...

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...

GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...